// App-Quantinova.ai

10136 : Phase III open label randomized controlled trial comparing intravenous iron sucrose to oral ferrous sulphate (without erythropoiesis stimulating agents) in the treatment of cancer related iron deficiency anemia.

Researchers

Presenter

  • Vanita Noronha

Principal Investigators

  • Vijay Maruti Patil

  • Amit Joshi

  • Sucheta More

  • Supriya Goud

  • Sachin Punatar

  • Kumar Prabhash

Medical Centers

  • Tata Memorial Hospital, Mumbai, India

  • Tata Memorial Centre, Mumbai, India

Locations

  • India

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Anemia

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Iron sucrose

Outcome

  • N/A


Study Design

  • Randomized

  • Open Label

  • Controlled

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final